Get started
Author

Seung Tae Kim

Observed names: Kim, Seung Tae, Seung Tae Kim
Observed institutions: Samsung (South Korea), Samsung Medical Center, Samsung Advanced Institute of Technology (South Korea), Samsung Electronics (South Korea), Samsung Biomedical Research Institute, Sungkyunkwan University
ORCID: 0000-0001-7335-1846
Observed ORCID: 0000-0001-7335-1846
OpenAlex ID: A5113847464
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel
2019 · Jason Willis, Martina I. Lefterova, et al. · Clinical Cancer Research · 239
Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability–High Gastric Cancer
2021 · Minsuk Kwon, Minae An, et al. · Cancer Discovery · 238
Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial
2019 · Jeeyun Lee, Seung Tae Kim, et al. · Cancer Discovery · 228
Gastrointestinal malignancies harbor actionable MET exon 14 deletions
2015 · Jeeyun Lee, Jeeyun Lee, et al. · Oncotarget · 64
PDF
MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis
2016 · Ji Yun Lee, Ji Yun Lee, et al. · Oncotarget · 60
PDF
NTRK1 rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
2015 · Su Jin Lee, Gang Gary Li, et al. · Oncotarget · 58
PDF
Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion
2017 · Sun Young Kim, Sun Young Kim, et al. · Oncotarget · 47
PDF
Patient-derived cell models as preclinical tools for genome-directed targeted therapy
2015 · Ji Yun Lee, Ji Yun Lee, et al. · Oncotarget · 47
PDF
Comprehensive pharmacogenomic characterization of gastric cancer
2020 · Jason K. Sa, Jung Yong Hong, et al. · Genome Medicine · 46
PDF
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial
2019 · Rosalba Miceli, Jiyeong An, et al. · Oncology · 41
Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
2018 · Seung Tae Kim, Sun Young Kim, et al. · BMC Cancer · 37
PDF
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
2015 · Jeeyun Lee, Jeeyun Lee, et al. · Oncotarget · 37
PDF
The Influence of Metastatic Lymph Node Ratio on the Treatment Outcomes in the Adjuvant Chemoradiotherapy in Stomach Tumors (ARTIST) Trial: A Phase III Trial
2016 · Youjin Kim, Se Hoon Park, et al. · Journal of the Korean Gastric Cancer Association · 35
PDF
Host immune response index in gastric cancer identified by comprehensive analyses of tumor immunity
2017 · Charny Park, Junhun Cho, et al. · OncoImmunology · 33
PDF
Clinical sequencing to assess tumor mutational burden as a useful biomarker to immunotherapy in various solid tumors
2021 · Hana Kim, Jung Yong Hong, et al. · Therapeutic Advances in Medical Oncology · 31
PDF
The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)
2017 · Mi Hwa Heo, Hee Kyung Kim, et al. · Journal of Cancer · 29
PDF
Development of mesenchymal subtype gene signature for clinical application in gastric cancer
2017 · Jeeyun Lee, Razvan Cristescu, et al. · Oncotarget · 27
PDF
MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines
2017 · Jung Eun Kim, Youjin Kim, et al. · Oncotarget · 26
PDF
Dynamic modulation of claudin18.2 expression and remodeling of the tumor microenvironment in gastric cancer during chemo-immunotherapy
2025 · Sung Hee Lim, Takeshi Kuwata, et al. · Journal for ImmunoTherapy of Cancer · 25
PDF
NCOA4-RET fusion in colorectal cancer: Therapeutic challenge using patient-derived tumor cell lines
2018 · Sun Young Kim, Seiyoon Oh Oh, et al. · Journal of Cancer · 25
PDF
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study
2025 · Kohei Shitara, Sylvie Lorenzen, et al. · Journal of Clinical Oncology · 24
Catalytic Enantioselective Protonation/Nucleophilic Addition of Diazoesters with Chiral Oxazaborolidinium Ion Activated Carboxylic Acids
2017 · Ki‐Tae Kang, Seung Tae Kim, et al. · Angewandte Chemie International Edition · 24
The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
2016 · Sung Hee Lim, Sun-Young Kim, et al. · Oncotarget · 24
PDF
Enantioselective Friedel–Crafts Alkylation of Furans with o-Quinone Methide Using a Chiral Oxazaborolidinium Ion Catalyst
2022 · Yoon Sung Cho, Seung Tae Kim, et al. · Organic Letters · 23
Mechanisms of Acquired Resistance to Savolitinib, a Selective MET Inhibitor in MET -Amplified Gastric Cancer
2020 · Melanie M. Frigault, Aleksandra Markovets, et al. · JCO Precision Oncology · 23
PDF
Works count: 62
Citation count: 1,746
H-index: 24
I10-index: 33
Year
Topic
Type